Buprenorphine Extended-Release Injection and Mogamulizumab
Determining the interaction of Buprenorphine Extended-Release Injection and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Mogamulizumab-kpkc
- Buprenorphine Extended-Release Injection-Mogamulizumab-kpkc Intravenous
- Buprenorphine Extended-Release Injection-Molindone
- Buprenorphine Extended-Release Injection-Mometasone (Oral Inhalation)
- Buprenorphine Extended-Release Injection-Mometasone and Formoterol
- Buprenorphine Extended-Release Injection-Mometasone and formoterol Inhalation
- Mogamulizumab-Buprenorphine implant
- Mogamulizumab-Buprenorphine Injection
- Mogamulizumab-Buprenorphine injection - Buprenex
- Mogamulizumab-Buprenorphine injection - Sublocade
- Mogamulizumab-Buprenorphine Intradermal
- Mogamulizumab-Buprenorphine oral/buccal